If you read a recent doctor's report, you may see "MASLD" instead of "NAFLD". The renaming is more than new letters: it changes how doctors understand and treat fatty liver. Here are the key points.
What changed?
In June 2023, international liver societies (including the AASLD in the US and EASL in Europe) agreed on new names in a broad consensus process:
- NAFLD (non-alcoholic fatty liver disease) is now MASLD – metabolic dysfunction-associated steatotic liver disease.
- NASH (non-alcoholic steatohepatitis, fatty liver inflammation) is now MASH.
- New is MetALD for people who have metabolic risks and also drink more alcohol.
- The umbrella term for all forms is SLD (steatotic liver disease).
Why the new name?
1. Cause instead of exclusion: "non-alcoholic" described what the disease is not. "Metabolic" names the real driver – insulin resistance, overweight, high blood pressure, blood lipids, diabetes.
2. Less stigma: many patients found terms like "fatty" and "alcoholic" judgmental.
3. Clearer diagnosis: MASLD requires liver fat plus at least one of five cardiometabolic risk factors.
The five risk factors
- Overweight or a large waist circumference
- High blood sugar, prediabetes or type 2 diabetes
- High blood pressure or blood pressure medication
- High triglycerides or treatment for them
- Low HDL cholesterol or treatment for it
What it means for you
Treatment changes little – but the picture becomes clearer: fatty liver is part of a metabolic disease. To protect your liver, look after blood sugar, blood pressure, lipids and weight. Nearly all research on the old NAFLD still applies, because more than 95% of patients fall into both groups.
What actually helps is covered in our fatty liver guide, the list of foods to avoid and our article on liver enzymes.
New medications
The new understanding also brought new treatments: in 2024 the US FDA granted approval to resmetirom (Rezdiffra), the first drug specifically for MASH with moderate to advanced fibrosis. For most people, however, lifestyle remains the foundation.
When to see a doctor
If you have been diagnosed with fatty liver, ask whether scarring (fibrosis) is already present – for example with the FIB-4 score from blood tests or elastography (FibroScan).
Frequently asked questions
Is MASLD a different disease from NAFLD? No, essentially the same disease with a clearer definition. More than 95% of NAFLD patients also meet MASLD criteria.
Can I drink alcohol with MASLD? As little as possible. With higher intake the diagnosis becomes MetALD; with fibrosis, avoiding alcohol is advisable.
Can MASLD be reversed? Liver fat and inflammation can regress markedly with weight loss, often completely.
Supportive products for liver and metabolism can be found in our recommendations below.